Barriers and Facilitators to MMR Vaccination Among Healthcare Workers

Measles Clinical Trial

— BFMMRHCW  

Official title:

Exploring Barriers and Facilitators to Uptake of the MMR Vaccine Among Healthcare Workers at King's College Hospital NHS Foundation Trust

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06456788
• Other study ID #: 344919
• Status: Not yet recruiting
• Start date: July 2024
• Est. completion date: February 2025

Study information

• Verified date: May 2024
• Source: King's College London
• Contact: Nikki Heinze
• Phone: 004420 7848 5684
• Email: nikki.heinze[@]kcl.ac.uk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Measles is a highly contagious disease which can result in severe complications in some patients. Healthcare workers have a higher risk of getting measles than the general population because of their increased risk of exposure from patients with measles attending hospitals. Having had measles in the past or at least one dose of the measles, mumps and rubella (MMR) vaccine provides protection (immunity) against measles. UK government guidelines therefore recommend that healthcare workers and non-clinical staff with direct patient contact are fully vaccinated or have other evidence of immunity. Yet, evidence from recent measles outbreaks suggests that some healthcare workers are not immune or do not know if they are immune, with implications for containment efforts, cost and transmission. The purpose of this study is to identify barriers and facilitators to uptake of the MMR vaccine among healthcare workers at King's College Hospital NHS Foundation Trust (KCH). KCH healthcare workers will be eligible to take part in the study if they are aged 18 and over and have direct contact with patients. In addition, the research will focus on four subgroups of healthcare workers at KCH: those who are not immune, those who have not completed the full vaccination schedule, those who don't know their immunity status, those received the vaccine only after joining KCH. The latter may provide insights into facilitators to vaccine uptake. Measles immunity forms part of the occupational health screening at KCH. A series of semi structured interviews lasting approximately 1 hour will explore participants' experiences of the occupational health vaccine screening process and measles vaccine campaigns at KCH; why they are unvaccinated/not fully vaccinated/do not know if they are immune/decided to be vaccinated after joining KCH; and what measures or interventions may help healthcare workers when deciding whether to get the MMR vaccine.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: February 2025
• Est. primary completion date: October 2024
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Are aged 18 and over
• Currently work as a healthcare worker at KCH
• Have direct contact with patients
• Don't know if they have had measles and don't know if they have been vaccinated
• Or: Have not had measles and have not received the MMR vaccine
• Or: Have only received 1 dose of the MMR vaccine
• Or: Received the MMR vaccine after joining KCH

Exclusion Criteria:

• Are aged <18 years old
• Work in a role at KCH that does not involve direct contact with patients (e.g., administrative or business staff)
• Have had measles in the past or both doses of the MMR vaccine before joining KCH
• Are not able to give informed consent

Related Conditions & MeSH terms

• Measles

Intervention

Biological:
• MMR vaccination
MMR vaccination status

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
King's College London	King's College Hospital NHS Trust, UK Health Security Agency

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Barriers to MMR vaccination	Barriers to MMR vaccination will be explored in the qualitative interview	Collected at one timepoint 1 day during qualitative interview
Primary	Facilitators to MMR vaccination	Facilitators to MMR vaccination will be explored in the qualitative interview	Collected at one timepoint 1 day during qualitative interview
Primary	Reasons for not knowing immunity status	Reasons for not knowing immunity status will be explored in the qualitative interview	Collected at one timepoint 1 day during qualitative interview
Secondary	Experiences of the occupational health vaccine screening process at KCH	Experiences of the occupational health vaccine screening process at KCH will be explored in the qualitative interview	Collected at one timepoint 1 day during qualitative interview